Intervention not reported
New/intensified lipid‐lowering medication · adults without prevalent cardiovascular disease (primary cardiovascular disease prevention)
The intervention may leads to higher new/intensified lipid‐lowering medication (low certainty).
1 finding from 1 review
Intervention not reported
New/intensified antihypertensive medication · adults without prevalent cardiovascular disease (primary cardiovascular disease prevention)
The intervention may leads to higher new/intensified antihypertensive medication (low certainty).
1 finding from 1 review
Percentage of time within the therapeutic range · oral anticoagulant therapy in patients with atrial fibrillation
1 finding from 1 review
Anxiety · oral anticoagulant therapy in patients with atrial fibrillation
1 finding from 1 review
Depression Measured after 52 weeks HADS depression score, 0‐21 points Low score means fewer symptoms · oral anticoagulant therapy in patients with atrial fibrillation
1 finding from 1 review
Decisional conflict · oral anticoagulant therapy in patients with atrial fibrillation
1 finding from 1 review
Intervention not reported
Total mortality at the end of the · patients with coronary heart disease
The intervention showed no clear difference in total mortality at the end of the (moderate certainty).
1 finding from 1 review
Intervention not reported
Fatal and/or non‐fatal MI at the end of the · patients with coronary heart disease
It is very uncertain whether the intervention changes fatal and/or non‐fatal MI at the end of the (very low certainty).
1 finding from 1 review
Intervention not reported
Other fatal and/or non‐fatal cardiovascular events · patients with coronary heart disease
The intervention may leads to lower other fatal and/or non‐fatal cardiovascular events (low certainty).
1 finding from 1 review
Intervention not reported
Total revascularisations (including CABG and PCI) · patients with coronary heart disease
It is very uncertain whether the intervention changes total revascularisations (including CABG and PCI) (very low certainty).
1 finding from 1 review
Intervention not reported
Hospitalisations (cardiac‐related)at end of · patients with coronary heart disease
It is very uncertain whether the intervention changes hospitalisations (cardiac‐related)at end of (very low certainty).
1 finding from 1 review
Intervention not reported
All cause withdrawal at · patients with coronary heart disease
The intervention showed no clear difference in all cause withdrawal at (low certainty).
1 finding from 1 review
Intervention not reported
HRQoLVarious HRQoL measures · patients with coronary heart disease
1 finding from 1 review
Intervention not reported
Overall mortality ( · people with or at risk of cardiovascular disease
The intervention showed no clear difference in overall mortality ( (high certainty).
1 finding from 1 review
Intervention not reported
Cardiovascular mortality ( · people with or at risk of cardiovascular disease
The intervention showed no clear difference in cardiovascular mortality ( (moderate certainty).
1 finding from 1 review
Intervention not reported
Non‐cardiovascular mortality ( · people with or at risk of cardiovascular disease
The intervention showed no clear difference in non‐cardiovascular mortality ( (high certainty).
1 finding from 1 review
Intervention not reported
Fatal or non‐fatal myocardial infarction ( · people with or at risk of cardiovascular disease
The intervention showed no clear difference in fatal or non‐fatal myocardial infarction ( (moderate certainty).
1 finding from 1 review
Intervention not reported
Fatal and non‐fatal stroke ( · people with or at risk of cardiovascular disease
The intervention showed no clear difference in fatal and non‐fatal stroke ( (low certainty).
1 finding from 1 review
Intervention not reported
Discontinuation of treatment due to side effects ( · people with or at risk of cardiovascular disease
The intervention probably leads to higher discontinuation of treatment due to side effects ( (moderate certainty).
1 finding from 1 review
Intervention not reported
All‐cause mortality Median · adults older than 18 years, with no restriction regarding presence of ASCVD; participants generally had elevated risk of ASCVD (as…
The intervention showed no clear difference in all‐cause mortality Median (low certainty).
1 finding from 1 review